House CCP Committee Examines China’s Role in US Drug Supply

The House Select Committee on the Chinese Communist Party holds a hearing at 10 a.m. ET on March 18 titled “From the Science Lab to the Medicine Cabinet: How China is Cornering the Market on Our Medicines.”

Witnesses:

• Patrick Cashman, president of USAntibiotics
• Francisco Gimenez, partner at 8VC
• Dr. Marta E. Wosińska, senior fellow in economic studies at the Center on Health Policy at Brookings